Explore 3 Stock Ideas & Industry Insights Download Free Report

800-234-336
Shopping Cart 0
countryflagNZ
Login

Pro Medicus Ltd

Healthcare AU PME

159.23AUD
-0.4(0.25%)

Last update at 2026-06-04T06:12:00Z

Day Range

157.86164.65
LowHigh

52 Week Range

107.45334.73
LowHigh

Fundamentals

  • Previous Close 159.63
  • Market Cap13599.90M
  • Volume454115
  • P/E Ratio57.86
  • Dividend Yield0.47%
  • EBITDA178.91M
  • Revenue TTM240.57M
  • Revenue Per Share TTM2.30
  • Gross Profit TTM 240.25M
  • Diluted EPS TTM2.25

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax 163.31M 116.50M 86.13M 63.08M 42.87M
Minority interest - - - - -
Net income 115.22M 82.79M 60.65M 44.44M 30.85M
Selling general administrative 36.28M 30.38M 24.07M 15.40M 13.53M
Selling and marketing expenses 3.74M 2.89M 2.52M 1.95M 0.32M
Gross profit 212.60M 122.24M 124.24M 92.94M 67.35M
Reconciled depreciation 7.24M 8.51M 7.93M 7.32M 7.20M
Ebit 157.61M 112.18M 83.76M 62.33M 42.33M
Ebitda 164.85M 120.69M 91.69M 69.64M 49.53M
Depreciation and amortization 7.24M 8.51M 7.93M 7.32M 7.20M
Non operating income net other - - - - -
Operating income 157.61M 112.18M 84.08M 61.31M 42.63M
Other operating expenses 55.29M 49.25M 40.12M 30.10M 24.21M
Interest expense 1.94M 1.12M 0.39M 0.65M 0.54M
Tax provision 48.09M 33.70M 25.48M 18.64M 12.02M
Interest income 7.56M 4.83M 2.43M 0.65M 0.18M
Net interest income 7.56M 4.83M 2.43M 0.65M 0.18M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 48.09M 33.70M 25.48M 18.64M 12.02M
Total revenue 212.91M 161.43M 124.79M 93.40M 67.84M
Total operating expenses 54.98M 48.95M 40.48M 30.61M 25.01M
Cost of revenue 0.31M 39.19M 0.54M 0.47M 0.49M
Total other income expense net 5.70M 4.32M -0.06600M 0.10M 0.36M
Discontinued operations - - - - -
Net income from continuing ops 115.22M 82.79M 60.65M 44.44M 30.85M
Net income applicable to common shares 115.22M 82.79M 60.65M 44.44M 30.85M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 338.70M 257.43M 202.13M 157.05M 125.57M
Intangible assets 20.77M 20.07M 21.35M 22.29M 20.01M
Earning assets - - - - -
Other current assets 6.58M 1.89M 0.78M 0.45M 1.57M
Total liab 81.74M 69.70M 63.36M 55.32M 43.89M
Total stockholder equity 256.96M 187.73M 138.78M 101.73M 81.68M
Deferred long term liab - - 2.36M 1.47M 1.35M
Other current liab 21.31M 15.21M 16.56M 14.48M 7.29M
Common stock 34.73M 23.65M 1.96M 1.96M 1.96M
Capital stock 34.73M 23.65M 1.96M 1.96M 1.96M
Retained earnings 239.46M 173.36M 127.12M 92.58M 66.92M
Other liab - - 31.31M 26.78M 24.23M
Good will - - - - -
Other assets - 0.00000M 12.45M 47.19M 43.03M
Cash 174.54M 60.06M 91.25M 63.66M 42.04M
Cash and equivalents - - - - -
Total current liabilities 43.14M 34.56M 30.85M 26.86M 17.62M
Current deferred revenue 19.11M 17.05M 12.60M 10.13M 8.89M
Net debt -172.28100M -57.99300M -89.39700M -61.37700M -39.42100M
Short term debt 1.32M 0.55M 0.65M 0.60M 0.57M
Short long term debt - - - - -
Short long term debt total 2.25M 2.07M 1.85M 2.28M 2.62M
Other stockholder equity - - -129.07500M -94.53500M -68.88400M
Property plant equipment - - 2.19M 2.60M 3.01M
Total current assets 280.09M 206.56M 163.79M 119.82M 87.57M
Long term investments 7.34M 7.34M - - -
Net tangible assets - - 117.43M 79.44M 61.67M
Short term investments 34.65M 95.36M 30.25M 26.90M 19.78M
Net receivables 64.23M 49.20M 39.88M 27.44M 22.84M
Long term debt - - - - -
Inventory 0.10M 0.05M 0.06M 0.08M 0.03M
Accounts payable 1.41M 1.74M 1.03M 1.64M 0.87M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -17.23000M -9.27700M 9.70M 7.20M 12.80M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 3.94M 0.04M 2.60M 1.47M 1.39M
Deferred long term asset charges - - - - -
Non current assets total 58.61M 50.86M 38.34M 37.23M 38.01M
Capital lease obligations 2.25M 2.07M 1.85M 2.28M 2.62M
Long term debt total - - 1.20M 1.68M 2.04M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments -6.57700M -73.27700M -7.55700M -8.53300M -19.70400M
Change to liabilities - - 7.14M 8.10M 4.16M
Total cashflows from investing activities -6.57700M -78.07400M -7.55700M -16.90700M -27.21700M
Net borrowings - - -0.57400M -0.50900M -0.50100M
Total cash from financing activities -57.61800M -39.84100M -27.52700M -23.31400M -14.04900M
Change to operating activities - - 0.27M 0.35M 0.26M
Net income 115.22M 82.79M 60.65M 44.44M 30.85M
Change in cash 47.42M -31.18600M 27.59M 21.62M -1.37400M
Begin period cash flow 60.06M 91.25M 63.66M 42.04M 43.41M
End period cash flow 107.49M 60.06M 91.25M 63.66M 42.04M
Total cash from operating activities 111.33M 86.78M 62.53M 61.58M 38.84M
Issuance of capital stock - - - - -
Depreciation - 8.51M 0.83M 0.81M 0.80M
Other cashflows from investing activities -2.59000M -63.85700M -1.11100M 0.65M 0.18M
Dividends paid -49.11400M -36.55400M 26.11M 18.79M 13.55M
Change to inventory -0.04900M 0.00600M 0.02M -0.04300M 0.00100M
Change to account receivables -16.18000M -9.99300M -13.47800M -3.59100M -9.53900M
Sale purchase of stock -7.85300M -2.76900M -0.84500M -4.01700M -4.01700M
Other cashflows from financing activities -0.65100M -0.51800M -0.57400M -0.50900M -0.50100M
Change to netincome - - -0.24000M 0.40M 2.07M
Capital expenditures 7.38M 6.69M 6.45M 9.02M 7.69M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -13.13000M -8.45100M -13.45600M -3.63400M -9.53800M
Stock based compensation - - 1.23M 0.03M 0.68M
Other non cash items 124.46M 86.72M 1.05M 16.32M 7.19M
Free cash flow 103.95M 80.08M 56.09M 52.55M 31.15M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
PME
Pro Medicus Ltd		 -0.4 0.25% 159.23 57.86 74.07 56.53 35.08 55.81 72.13
EIQ
Echoiq Ltd		 -0.01 0.75% 1.32 - - 9195.91 48.41 9072.58 -8.2701
AYA
ARTRYA Ltd		 0.11 2.36% 4.77 - - 25742.94 8.36 8076.24 0.33
CGS
Cogstate Ltd		 -0.01 0.40% 2.49 28.89 24.33 7.93 6.20 5.35 16.64
ONE
Oneview Healthcare Plc		 - -% 0.17 - - 12.84 25.31 7.39 -3.5247

Reports Covered

Stock Research & News

View All

Profile

Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software. It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform for secure email and integration products. In addition, the company offers Visage Ease, a mobile application that provides users access to medical imaging results; and Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.

Pro Medicus Ltd

450 Swan Street, Richmond, VIC, Australia, 3121

Key Executives

Name Title Year Born
Dr. Sam Aaron Hupert M.B.B.S., M.D. Co-Founder, CEO, MD & Exec. Director NA
Mr. Anthony Barry Hall B.Sc., B.Sc.(Hons), M.Sc. Co-Founder, Technology Director & Exec. Director NA
Mr. Clayton James Hatch CPA, B.Comm, CPA CFO & Company Sec. NA
Dr. Malte Westerhoff GM of Europe & Global CTO NA
Mr. Brad Levin GM of North America & Global Head of Marketing NA
Mr. Sean Lambright Global Head of Sales - Visage Imaging Inc NA
Ms. Teresa Gschwind Global Head of Customer Service of Visage Imaging Inc. NA
Dr. Sam Aaron Hupert M.B.B.S., M.D. Co-Founder, CEO, MD & Executive Director NA
Mr. Anthony Barry Hall B.Sc., B.Sc.(Hons), M.Sc. Co-Founder, Technology Director & Executive Director NA
Mr. Clayton James Hatch B.Comm, CPA, CPA Chief Financial Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.